Skip to main content
Fig. 1 | Journal of Translational Medicine

Fig. 1

From: Establishment of a high-fidelity patient-derived xenograft model for cervical cancer enables the evaluation of patient’s response to conventional and novel therapies

Fig. 1

Flowchart of the patient-derived xenograft (PDX) process. a Generation process of PDX: (1) The patient’s primary tumor was collected and (2) cut into small pieces (3–4 mm), divided into several parts for subsequent (3) transplantation into the flanks of NOD/SCID (subcutaneously). (4) The growth of P1 generation PDX tumor was observed and recorded. (5) When the PDX tumor grew to 1500 mm3 in size, its growth time was recorded. The PDX tumor was obtained, and (6) was cut again to 3 mm in size (7) for the subsequent establishment of P2 to P4 generations PDX tumors. (8) Finally, PDX tumors of different generations were cut and frozen for sequencing or other experiments. b The growth time of different generations of PDX tumor (P1–P4). P1 (n = 44; range, 21–181 [mean = 65] days), P2 (n = 35; range, 8–47 [mean = 25] days), P3 (n = 13; range, 8–35 [mean = 18] days), and P4 (n = 3; range, 8–18 [mean = 13] days)

Back to article page